ArticleClinical and translational science2024

Population pharmacokinetics and exposure-response analyses for efficacy and safety of upadacitinib in patients with axial spondyloarthritis.

Sumit Bhatnagar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.